MedPath
Found 1 clinical trials|View Analysis
Sort by:

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Phase 2
Completed
Conditions
Skin Cancer
Melanoma
Interventions
First Posted Date
2009-06-18
Last Posted Date
2015-10-28
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
4
Registration Number
NCT00923195
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath